LIVN News and Press, LivaNova PLC From 02/24/21

Image source: The Motley Fool. LivaNova PLC (NASDAQ: LIVN) Q4 2020 Earnings Call Feb 24, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: LivaNova PLC (LIVN) Q4 2020 Earnings Call Transcript

LivaNova PLC (LIVN): Q4 Non-GAAP EPS of $0.71 beats by $0.03; GAAP EPS of -$5.74 misses by $4.49.Revenue of $269.6M (-6.3% Y/Y) beats by $0.77M.2021 Guidance:  LivaNova expects worldwide net sales from continuing operations for full-year 2021 to grow between 8 and 13 percent on a co...

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2020. For the fourth quarter of 2020, worldwide sales from continuing operations were $269.6 million, a decrease of 6.3 pe...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2020 results on Wednesday, February 24, 2021 at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its...

LivaNova has upside levers in place to drive top-line growth over the coming periods, with a sequential growth pattern from Q2 to Q3. The company recently sold its heart valves arm, removing this underperforming segment of the portfolio, thus widening capital allocation opportunities....

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company’s governance. Todd Schermerhorn has been appointed to the Board of Directors, effective December 3. Schermerhorn has 35 years of exp...

Company to also share new data via poster presentations LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will host “ Updates and Advances in Neuromodulation ,” a satellite symposium at AES2020, the v...

LivaNova (LIVN) inks an agreement to sell its LivaNova heart valve business ((HV)) to Gyrus Capital, an investment firm dedicated to investments in the healthcare and sustainability sectors.Upon completion of the transaction, Gyrus intends to focus management attention and inve...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and co...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Berenberg European Conference 2020. The discussion is scheduled to begin at 4 p.m. Greenwich Mean Time on Wednesd...